4.37
price down icon3.10%   -0.14
after-market Dopo l'orario di chiusura: 4.37
loading

Olema Pharmaceuticals Inc Borsa (OLMA) Ultime notizie

pulisher
Mar 12, 2025

Olema Pharmaceuticals (NASDAQ:OLMA) Receives Buy Rating from HC Wainwright - MarketBeat

Mar 12, 2025
pulisher
Mar 11, 2025

Olema Pharmaceuticals stock hits 52-week low at $4.05 - Investing.com

Mar 11, 2025
pulisher
Mar 11, 2025

Promising Efficacy of Olema Pharmaceuticals’ Palazestrant Supports Buy Rating - TipRanks

Mar 11, 2025
pulisher
Mar 11, 2025

Olema Pharmaceuticals stock hits 52-week low at $4.05 By Investing.com - Investing.com UK

Mar 11, 2025
pulisher
Mar 10, 2025

Olema Pharmaceuticals (NASDAQ:OLMA) Given Buy Rating at HC Wainwright - MarketBeat

Mar 10, 2025
pulisher
Mar 07, 2025

Olema Pharmaceuticals (NASDAQ:OLMA) Earns “Buy” Rating from HC Wainwright - Defense World

Mar 07, 2025
pulisher
Mar 07, 2025

Olema Pharmaceuticals: Promising Clinical Results and Strong Financial Health Support Buy Rating - TipRanks

Mar 07, 2025
pulisher
Mar 06, 2025

Olema Pharmaceuticals (OLMA) Expected to Announce Earnings on Monday - MarketBeat

Mar 06, 2025
pulisher
Mar 06, 2025

Olema updated palazestrant combination trial, says Oppenheimer - MSN

Mar 06, 2025
pulisher
Mar 06, 2025

Olema Pharmaceuticals stock holds $30 target at H.C. Wainwright By Investing.com - Investing.com UK

Mar 06, 2025
pulisher
Mar 06, 2025

Y Intercept Hong Kong Ltd Buys Shares of 19,001 Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World

Mar 06, 2025
pulisher
Mar 05, 2025

Promising Efficacy of Olema Pharmaceuticals’ Breast Cancer Treatment Drives Buy Rating - TipRanks

Mar 05, 2025
pulisher
Mar 05, 2025

Olema Pharmaceuticals Unveils Strategic Priorities and Pipeline - TipRanks

Mar 05, 2025
pulisher
Mar 04, 2025

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Mar 04, 2025
pulisher
Mar 04, 2025

Olema's New Chief Legal Officer Receives 450,000 Stock Options as Part of Inducement Grants - StockTitan

Mar 04, 2025
pulisher
Feb 26, 2025

Promising Developments in Olema Pharmaceuticals’ Breast Cancer Treatment Drive Buy Rating - TipRanks

Feb 26, 2025
pulisher
Feb 26, 2025

AstraZeneca data ‘positive’ for Olema’s palazestrant, says H.C. Wainwright - TipRanks

Feb 26, 2025
pulisher
Feb 25, 2025

Olema Pharmaceuticals stock hits 52-week low at $4.59 By Investing.com - Investing.com South Africa

Feb 25, 2025
pulisher
Feb 25, 2025

Olema Pharmaceuticals stock hits 52-week low at $4.59 - Investing.com India

Feb 25, 2025
pulisher
Feb 24, 2025

When the Price of (OLMA) Talks, People Listen - Stock Traders Daily

Feb 24, 2025
pulisher
Feb 23, 2025

Vontobel Holding Ltd. Acquires Shares of 10,647 Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World

Feb 23, 2025
pulisher
Feb 20, 2025

Olema Oncology to Present at the TD Cowen 45th Annual Health Care Conference - GlobeNewswire

Feb 20, 2025
pulisher
Feb 19, 2025

Can Olema's Breast Cancer Breakthrough Transform Patient Care? CEO Reveals Latest Data - StockTitan

Feb 19, 2025
pulisher
Feb 18, 2025

Mehta named CMO, Greenberg CBO at Nura Bio - BioCentury

Feb 18, 2025
pulisher
Feb 18, 2025

Olema Oncology Appoints Shawnte M. Mitchell, J.D. as Chief Legal Officer and Corporate Secretary - GlobeNewswire

Feb 18, 2025
pulisher
Feb 18, 2025

Key Executive Hire: Biotech Veteran with 20-Year Track Record Joins Olema's C-Suite - StockTitan

Feb 18, 2025
pulisher
Feb 17, 2025

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Short Interest Down 22.6% in January - MarketBeat

Feb 17, 2025
pulisher
Feb 17, 2025

Olema Pharmaceuticals (NASDAQ:OLMA) Stock Price Down 5.4%Should You Sell? - MarketBeat

Feb 17, 2025
pulisher
Feb 16, 2025

Olema Pharmaceuticals: Interesting But Undifferentiated Data (NASDAQ:OLMA) - Seeking Alpha

Feb 16, 2025
pulisher
Feb 13, 2025

Olema Pharmaceuticals Inc (NASDAQ: OLMA) Slashes -5.36%: What Could Be On The Way Going Forward? - Stocks Register

Feb 13, 2025
pulisher
Feb 13, 2025

SG Americas Securities LLC Has $102,000 Stock Holdings in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World

Feb 13, 2025
pulisher
Feb 11, 2025

OLMA’s Market Quandary: Decoding the Ups and Downs of 2023 - The InvestChronicle

Feb 11, 2025
pulisher
Feb 10, 2025

Upward Trajectory: Olema Pharmaceuticals Inc (OLMA) Posts a Slidee, Closing at 5.69 - The Dwinnex

Feb 10, 2025
pulisher
Feb 07, 2025

The Significance of Moving Averages in Olema Pharmaceuticals Inc Inc. (OLMA) Price Performance - The InvestChronicle

Feb 07, 2025
pulisher
Feb 06, 2025

There is no way Olema Pharmaceuticals Inc (OLMA) can keep these numbers up - SETE News

Feb 06, 2025
pulisher
Feb 04, 2025

OLMAOlema Pharmaceuticals, Inc. Latest Stock News & Market Updates - StockTitan

Feb 04, 2025
pulisher
Feb 04, 2025

Olema Pharma's Strategic Talent Acquisition: $1.7M in Equity Grants Signals Growth Push - StockTitan

Feb 04, 2025
pulisher
Feb 04, 2025

Olema Pharmaceuticals Inc (OLMA) Becoming More Attractive for Investors - Knox Daily

Feb 04, 2025
pulisher
Feb 04, 2025

Are Olema Pharmaceuticals Inc (OLMA) shares a good deal now? - US Post News

Feb 04, 2025
pulisher
Feb 04, 2025

Financial Metrics Exploration: Understanding Olema Pharmaceuticals Inc (OLMA) Through Ratios - The Dwinnex

Feb 04, 2025
pulisher
Feb 03, 2025

Olema Oncology to Participate in Upcoming Investor Conferences - The Manila Times

Feb 03, 2025
pulisher
Feb 03, 2025

Exclusive Access: Olema Pharmaceuticals Reveals Latest Oncology Progress at Two Elite Healthcare Forums - StockTitan

Feb 03, 2025
$75.07
price up icon 1.39%
$305.39
price down icon 0.55%
$19.19
price down icon 3.62%
$32.68
price down icon 0.52%
$97.47
price down icon 2.84%
biotechnology ONC
$254.57
price up icon 1.89%
Capitalizzazione:     |  Volume (24 ore):